Bluejay completes Toray manufacturing-site milestone ahead of Oct 23 deadline

Bluejay Diagnostics, Inc.

Bluejay formally notified Toray Industries it substantially completed establishment of a Symphony cartridge manufacturing site, ahead of the October 23, 2026 contractual deadline.
Manufacturing split across SanyoSeiko Co., Ltd. in Japan (the site under the Toray agreement) and ALURIS Sciences, formerly Argonaut Manufacturing Services, in the U.S.
Symphony IL-6 Test, the first product candidate, is not FDA cleared or approved and remains limited to investigational use in the U.S.; no financial terms disclosed.
Regulatory path runs through the SYMON studies: SYMON-I (NCT06181604), pivotal SYMON-II (NCT06654895) to support a 510(k), and SYMON-III (NCT07425587).

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.